Dr Michelle Perugini
Dr Michelle Perugini is an entrepreneur, academic and an internationally renowned expert in health, medical research, advanced analytics, and cognitive AI. Michelle spent the first 13 years of her career in health and medical research, specialising in predictive genetics and translational medicine. Michelle led large complex research projects that translated genetic mutation analysis (bioinformatics) to clinical treatments for cancer patients. She was also the pioneer of new methods in proteomics that now drive drug discovery.
In 2007 Michelle co-founded the innovative start-up ISD Analytics where she led the research and development, and commercialisation, of its award¬ winning human-population behaviour predictive analytics software product Simulait. ISD Analytics was acquired by Ernst & Young (EY) in 2015 and became one of EY’s global suite of analytics products.
Michelle is now working with and mentoring various innovative technology start-ups, and is a co-founder and CEO of Presagen and Life Whisperer.
Presagen is changing the way medical data from around the world is connected with artificial intelligence, to build globally scalable and unbiased medical products across all industries in healthcare. Presagen’s AI Open Projects in an online platform that safely connects data from clinics globally to co-develop medical AI products that can be delivered at scale and at low cost.
Presagen’s first product is Life Whisperer. Life Whisperer uses artificial intelligence (AI) to better identify healthy embryos for IVF, and to ultimately improve outcomes for couples wanting to have children.